uce
ProgressImage ProgressImage
Jubilant Pharmova Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 530019 border-img ISIN Demat INE700A01033 border-img Book Value 146.90 border-img NSE Symbol JUBLPHARMA border-img Div & Yield % 0.74 border-img Market Cap ( Cr.) 10721.69 border-img P/E 0 border-img EPS 0 border-img Face Value 1
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales170.20179.40203.90
Other Operating Income5.006.9013.50
Other Income 19.0018.4015.90
Total Income194.20204.70233.30
Total Expenditure 175.90185.50213.20
PBIDT18.3019.2020.10
Interest 8.307.106.40
PBDT10.0012.1013.70
Depreciation12.3011.9011.40
Tax-0.400.000.40
Fringe Benefit Tax0.000.000.00
Deferred Tax0.500.600.00
Reported Profit After Tax-2.40-0.401.90
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-2.40-0.401.90
    
EPS (Unit Curr.)-0.15-0.030.12
EPS (Adj) (Unit Curr.)-0.15-0.030.12
Calculated EPS (Unit Curr.)-0.15-0.030.12
Calculated EPS (Adj) (Unit Curr.)-0.15-0.030.12
Calculated EPS (Ann.) (Unit Curr.)-0.60-0.100.48
Calculated EPS (Adj) (Ann.) (Unit Curr.)-0.60-0.100.48
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity15.9015.9015.90
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)10.7510.709.86
PBDTM(%)5.886.746.72
PATM(%)-1.41-0.220.93
x
x
×
Let's Chat
close
refresh